AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Darunavir in Nigeria
10 products registered with NAFDAC — 9 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Prezista 600 mg Tablet** Tablet | A4-7676 | Blooms Pharm Ltd | active | 26 May 2030 |
| Prezista 75 mg Tablet Tablet | B4-7649 | Blooms Pharm Ltd | active | 26 Jun 2029 |
| Prezista 150 mg Tablet Tablet | B4-7650 | Blooms Pharm Ltd | active | 26 Jun 2029 |
| Durart 800 mg Tablet** Tablet | C4-1775 | Healthline Limited | active | 2 Aug 2026 |
| Durart 600 mg Tablet** Tablet | C4-1776 | Healthline Limited | active | 2 Aug 2026 |
| Darunavir Tablets 600 mg (check composition) Tablet | A4-100044 | Jyna Pharma Ltd | active | 6 May 2026 |
| Darunavir Tablets 800 mg Tablet | A4-100043 | Jyna Pharma Ltd | active | 6 May 2026 |
| Darunavir Tablets 600 mg Tablet | B4-2780 | Hetero Labs Nigeria Limited | active | 6 May 2026 |
| Darunavir Tablets 400 mg Tablet | A4-100045 | Jyna Pharma Ltd | active | 6 May 2026 |
| PREZISTA TABLET 1 X 60 TABLETS | B4-6132 | BLOOMS PHARM LTD. NO. 42 | expired | 27 Jan 2021 |
Darunavir — NAFDAC Registration Details
NAFDAC (Nigeria) has 10 registered products containing Darunavir, of which 9 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Darunavir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.